Zobrazeno 1 - 10
of 14
pro vyhledávání: '"F Meiring, Nortier"'
Autor:
Tara Mastren, Valery Radchenko, Philip D Hopkins, Jonathan W Engle, John W Weidner, Roy Copping, Mark Brugh, F Meiring Nortier, Eva R Birnbaum, Kevin D John, Michael Ernst-Heinrich Fassbender
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0190308 (2017)
Ruthenium-103 is the parent isotope of 103mRh (t1/2 56.1 min), an isotope of interest for Auger electron therapy. During the proton irradiation of thorium targets, large amounts of 103Ru are generated through proton induced fission. The development o
Externí odkaz:
https://doaj.org/article/eb2b44ace77b4b0190e5973af9c40b82
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
Autor:
Olivier Rixe, F. Meiring Nortier, Mehran Makvandi, Sam Simon, Jonathan W. Engle, Jeffrey P. Norenberg, Robert W. Atcher, Michael E. Fassbender, Edouard Dupis, Kevin D. John, Eva R. Birnbaum
Publikováno v:
Targeted Oncology. 13:189-203
Alpha-emitters are radionuclides that decay through the emission of high linear energy transfer α-particles and possess favorable pharmacologic profiles for cancer treatment. When coupled with monoclonal antibodies, peptides, small molecules, or nan
Autor:
Tara Mastren, F. Meiring Nortier, Eva R. Birnbaum, John W. Weidner, Roy Copping, Mark Brugh, Michael E. Fassbender, Kevin D. John, Valery Radchenko, Jonathan W. Engle, Allison Owens, Lance E. Wyant
Publikováno v:
Analytica Chimica Acta. 998:75-82
Column chromatographic methods have been developed to separate no-carrier-added 111Ag from proton irradiated thorium targets and associated fission products as an ancillary process to an existing 225Ac separation design. Herein we report the separati
Autor:
Valery Radchenko, Tara Mastren, Kevin D. John, Cathy S. Cutler, F. Meiring Nortier, Dmitri Medvedev, George A. Unc, Eva R. Birnbaum, Michael E. Fassbender, Joel M. Maassen, Leonard F. Mausner, Mark Brugh, Cleo Naranjo, Jonathan W. Engle, Catherine Meyer
Publikováno v:
Nuclear Medicine and Biology. 50:25-32
Scandium-44g (half-life 3.97h) shows promise for application in positron emission tomography (PET), due to favorable decay parameters. One of the sources of 44gSc is the 44Ti/44gSc generator, which can conveniently provide this radioisotope on a dail
Autor:
Mitchell T, Friend, Tara, Mastren, T Gannon, Parker, Christiaan E, Vermeulen, Mark, Brugh, Eva R, Birnbaum, F Meiring, Nortier, Michael E, Fassbender
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 156
Uranium-230 (t
Autor:
Mitchell T. Friend, Eva R. Birnbaum, Mark Brugh, T. Gannon Parker, Tara Mastren, F. Meiring Nortier, Michael E. Fassbender, C. Vermeulen
Publikováno v:
Applied Radiation and Isotopes. 156:108973
Uranium-230 (t1/2 = 20.8 d) is an alpha-emitting radionuclide that has potential application in targeted alpha therapy (TAT) of cancer. Its parent isotope 230Pa (t1/2 = 17.4 d), can be produced by proton irradiation of thorium metal targets. Prelimin
Autor:
Lance E. Wyant, Eva R. Birnbaum, Michael E. Fassbender, Roy Copping, Stosh A. Kozimor, Mark Brugh, Allison Owens, T. Gannon Parker, Tara Mastren, Valery Radchenko, F. Meiring Nortier, Benjamin W. Stein, Kevin D. John
Publikováno v:
Analytical chemistry. 90(11)
Protactinium-230 (t1/2 = 17.4 d) is the parent isotope of 230U (t1/2 = 20.8 d), a radionuclide of interest for targeted alpha therapy (TAT). Column chromatographic methods have been developed to separate no-carrier-added 230Pa from proton irradiated
Autor:
Tara, Mastren, Valery, Radchenko, Jonathan W, Engle, John W, Weidner, Allison, Owens, Lance E, Wyant, Roy, Copping, Mark, Brugh, F Meiring, Nortier, Eva R, Birnbaum, Kevin D, John, Michael E, Fassbender
Publikováno v:
Analytica chimica acta. 998
Column chromatographic methods have been developed to separate no-carrier-added
Autor:
Eva R. Birnbaum, Silvia S. Jurisson, Alan R. Ketring, F. Meiring Nortier, Lindsay N. Redman, B. Ballard, W. A. Taylor, Kevin D. John, Cathy S. Cutler, Matthew D. Gott, D. Scott Wilbur, Michael E. Fassbender, Jonathan W. Engle, Joel R. Maassen
Publikováno v:
Radiochimica Acta. 102:325-332
Rhenium-186g is a radionuclide with a high potential for therapeutic applications. It emits therapeutic β − particles accompanied by low energy γ-rays, which allows for in-vivo tracking of the radiolabeled compound and dosimetry estimates. The cu
Autor:
Valery, Radchenko, Jonathan W, Engle, Dmitri G, Medvedev, Joel M, Maassen, Cleo M, Naranjo, George A, Unc, Catherine A L, Meyer, Tara, Mastren, Mark, Brugh, Leonard, Mausner, Cathy S, Cutler, Eva R, Birnbaum, Kevin D, John, F Meiring, Nortier, Michael E, Fassbender
Publikováno v:
Nuclear medicine and biology. 50
Scandium-44g (half-life 3.97h) shows promise for application in positron emission tomography (PET), due to favorable decay parameters. One of the sources of